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ABSTRACT
H2A.Z, a variant of H2A, is found at the promoters of
inducible genes in both yeast and higher eukary-
otes. However, its role in transcriptional regulation
is complex since it has been reported to function
both as a repressor and activator. We have previ-
ously found that mono-ubiquitylation of H2A.Z is
linked to transcriptional silencing. Here, we
provide new evidence linking H2A.Z deubiquitylation
to transcription activation. We found that H2A.Z and
ubiquitin-specific protease 10 (USP10) are each
required for transcriptional activation of the
androgen receptor (AR)-regulated PSA and KLK3
genes. USP10 directly deubiquitylates H2A.Z
in vitro and in vivo, and reducing USP10 expression
in prostate cancer cells results in elevated
steady-state levels of mono-ubiquitylated H2A.Z
(H2A.Zub1). Moreover, knockdown of USP10
ablates hormone-induced deubiquitylation of chro-
matin proteins at the AR-regulated genes. Finally, by
sequential ChIP assays, we found that H2A.Zub1 is
enriched at the PSA and KLK3 regulatory regions,
and loss of H2A.Zub1 is associated with transcrip-
tional activation of these genes. Together, these
data provide novel insights into how H2A.Z
ubiquitylation/deubiquitylation and USP10 function
in AR-regulated gene expression.
INTRODUCTION
H2A.Z is a highly conserved variant of the canonical core
histone H2A. Various functions have been attributed to
H2A.Z, including prevention of heterochromatin
spreading (1), suppression of antisense RNAs (2) and
maintenance of chromosome stability and segregation
(3–5). By far, the strongest evidence links H2A.Z
function to regulation of gene transcription [reviewed in
(6,7)]. For example, Chromatin immunoprecipitation
(ChIP)-microarray and ChIP-sequencing (ChIP-seq)
studies showed that most genes have H2A.Z deposited
around their transcription start sites. Many studies have
also highlighted a dual role for H2A.Z in transcriptional
regulation, wherein it can act in either a negative or
positive manner [discussed in (8)]. How a single histone
variant can perform such contrasting functions is still
unclear. However, its ability to either repress or promote
transcription could be explained by differential
post-translational modiﬁcations (PTMs) that occur on
H2A.Z. For example, fractions of total H2A.Z are
acetylated or mono-ubiquitylated, and we have previously
hypothesized that these modiﬁcations distinguish H2A.Z’s
functions in activation or repression (6). In this regard, the
enzymes that modulate these respective modiﬁcations rep-
resent key regulatory components that dictate H2A.Z
functions.
Mammalian H2A.Z is known to be multiply acetylated
at several lysine residues (including K4, K7 and K11) at
the N-terminus (9–11). In contrast, mono-ubiquitylation
predominantly occurs at K120 at the C-terminus,
although K121 and K125 can serve as alternative
ubiquitylation sites (12). In yeast, H2A.Z is acetylated
by the NuA4 and GCN5 acetyltransferases (13–15).
Deﬁciency in H2A.Z acetylation leads to defects in
chromosome transmission and cell proliferation.
Furthermore, the acetylated form of H2A.Z is found at
the 50-end of active genes, suggesting a positive function
for this modiﬁed form of H2A.Z in transcriptional regu-
lation (15,16). Much less is known about H2A.Z
ubiquitylation other than that ubiquitylated H2A.Z
(H2A.Zub1) is enriched at facultative heterochromatin
in mammalian cells (12). Ubiquitylation of H2A.Z is
mediated by Ring1b, the E3 ligase member of the
polycomb repressive complex 1, suggesting that this
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Like many PTMs, ubiquitylation is also a reversible
reaction. Removal of ubiquitin is mediated by a
specialized class of enzymes called isopeptidases. These
deubiquitylating enzymes (DUBs) act by cleaving the
isopeptide bond that links ubiquitin to its substrate.
These enzymes are generally classiﬁed into ﬁve families
based on their catalytic domains: ubiquitin-speciﬁc prote-
ases (USPs), ubiquitin C-terminal hydrolases (UCHs),
ovarian tumour proteases (OTUs), Josephins and Jab1/
MPN/MOV34 metalloenzymes (JAMM/MPN+)
[reviewed in (17)]. USPs, UCHs, OTUs and Josephins
are all cysteine proteases, whereas the JAMM/MPN+
enzymes are zinc metalloproteases.
To date, several mammalian DUBs have been identiﬁed
to target H2Aub1, and many have been linked to tran-
scriptional activation [reviewed in (18)]. For example,
USP16 was ﬁrst described as a mitotic DUB targeting
H2Aub1 (19), and a recent report suggested that this
enzyme also regulates Hox gene expression (20).
Similarly, USP21 was found to promote transcription of
developmentally regulated genes in the liver presumably
through its deubiquitylation of H2Aub1 (21). Finally,
USP22 and the 2A-DUB (KIAA1915), both target
H2Aub1 (although USP22 can also deubiquitylate
H2Bub1), and both were described as co-activators of
androgen receptor (AR)-mediated transcription (22,23).
Thus far, an H2A.Z deubiquitylase has not been
reported. Given that H2A.Zub1 has also been linked to
repression of gene expression, we predicted that the DUB
for H2A.Z would have a transcriptional activation
function. In this regard, ubiquitin-speciﬁc protease 10
(USP10) has been implicated as a transcription
co-activator for AR-regulated genes (24) and, therefore,
we tested whether it might target H2A.Z. Indeed, in this
study, we found that USP10 deubiquitylates H2A.Zub1
and H2Aub1 in vitro and in vivo. Importantly, knockdown
of USP10 in prostate cancer cells increases the global
levels of H2A.Zub1 and H2Aub1, and prevents
deubiquitylation of chromatin proteins associated with
hormone-activated genes. USP10 and H2A.Z are each
required for AR-regulated gene transcription, and ChIP
assays showed that H2A.Z is directly associated with the
promoter and enhancer of the prostate-speciﬁc antigen
(PSA) and kallikrein-like 2 (KLK2) genes. Finally,
knockdown of USP10 also impairs the loss of H2A.Z at
the regulatory regions of PSA and KLK2 that normally
occurs during their transcriptional activation. Collectively,
our data support a novel role for H2A.Z in the regulation
of AR-mediated transcription that also involves the
deubiquitylating activity of USP10 towards histones.
MATERIALS AND METHODS
Cell culture, transfection, plasmids and antibodies
The 293T cells were grown in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum.
LNCaP cells were obtained from ATCC and PC-3 cells
stably expressing AR [PC-3(AR)] were courtesy of
Dr Theodore J. Brown (Mount Sinai Hospital, Toronto,
Canada). Both cell types were grown in RPMI 1640 media
supplemented with 10% fetal bovine serum. For culturing
in the absence of hormone, cells were grown in phenol-red
free RPMI 1640 supplemented with 5% charcoal-stripped
fetal bovine serum (Invitrogen) for 72 h prior to treatment
with hormone. Dihydrotestosterone (DHT) was obtained
from Sigma and re-suspended in absolute ethanol (EtOH);
DHT was added to cells at a ﬁnal concentration of 10nM,
or for control samples, an equivalent volume of EtOH
was added. All transfections were carried out using
Lipofectamine 2000 (Invitrogen). USP10 and histone ex-
pression constructs used were based on the pcDNA 3.1 (+)
(Invitrogen) backbone with the Flag tag cloned in-frame.
In co-transfection experiments, the ratio of the Flag-H2A/
Flag-H2A.Z to Flag-USP10 plasmids were either 1:1 or
1:3. The HA (hemagglutinin)-tagged ubiquitin construct,
cloned into the pMSCV vector, was courtesy of Dr
Dwayne Barber (Princess Margaret Hospital, Toronto,
ON, Canada). H2A.Z antibody directed against the L1
loop was described earlier (12), H2A acidic patch
antibody was from Upstate, H3 (ab1791) and USP10
antibodies were from Abcam, H2Bub1 monoclonal
antibody (NRO3) was from Me ´ diMabs, Flag M2 and
anti-His monoclonal antibodies were from Sigma, and
AR antibody (PG-21) was from Millipore. Anti-HA
Afﬁnity Matrix (Roche), containing rat monoclonal
antibody (clone 3F10) conjugated to agarose beads, was
used for HA ChIP experiments.
In vitro deubiquitylation assay
Deubiquitylases were cloned into the pVL1393 vector (BD
Biosciences) and His tag sequences were added in-frame to
the DUB cDNA. His-tagged recombinant protein was
generated using BaculoGold (BD) packaging vector in
the baculovirus expression system using standard tech-
niques, and puriﬁed via Ni-NTA agarose beads. Equal
amounts of puriﬁed DUBs (1.5mg each) were mixed with
2mg of total acid-soluble protein harvested from cells ex-
pressing either Flag-tagged H2A.Z or Flag-tagged H2A in
a buffer containing 60mM HEPES (4-2 [hydroxyethyl]-1-
piperazineethanesulfonic acid, pH 7.5), 5mM MgCl2,4 %
glycerol, 1mM EDTA, 1mM DTT plus fresh protease in-
hibitors. Reactions were incubated at 37 C for 30min.
The reactions were stopped by the addition of 2 
sample buffer and the samples were boiled for 5min.
Immunoﬂuorescence analysis
LNCaP cells were seeded on glass coverslips and grown as
described above. Immunoﬂuorescence (IF) analysis was
performed as described in (12) using anti-USP10 and
anti-AR antibodies.
Small-scale biochemical fractionation
Following treatment of cells with EtOH or 10nM DHT
for 2h, subcellular fractions of LNCaP cells were har-
vested using the Subcellular Protein Fractionation Kit
(Thermo Scientiﬁc) according to manufacturer’s instruc-
tions. Equal percentages (by volume) of each fraction were
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Stable shRNA and protein expression via retroviral
transduction of LNCaP cells
H2A.Z (cagctgtccagtgttggtg) and USP10 (gaatatcaga
gaattgagt) shRNA (short hairpin RNA) target sequences
were cloned into the pSUPER–retro–puro vector
(Oligoengine) as per manufacturer’s instructions. To
generate stable LNCaP cells, 7.0 10
5 cells were seeded
per well in 6-well dishes in RPMI 1640, 10% fetal bovine
serum. Twenty-four hours later, culture media was
replaced with 4ml of viral supernatant (containing 4mg/
ml of polybrene) and plates were centrifuged at 1500g for
4 h at 20 C. Following centrifugation, viral supernatant
was removed and replaced with fresh culture media.
Twenty-four hours later, cells were selected in 0.9mg/ml
puromycin for a minimum of 4 days, after which cells were
maintained in media containing 0.6mg/ml puromycin.
Luciferase assays
USP10 or P/CAF expression constructs, or their respect-
ive vector controls (pcDNA3.1 or pLNCX2), were trans-
fected into PC-3(AR) cells along with the AR-dependent
luciferase reporter, which contains three repeats of the
androgen response element (ARE) in its promoter. Cells
were lysed 48 h after transfection in cell culture lysis
reagent (Promega). Luciferase activities were measured
using the Luciferase assay system (Promega) according
to the manufacturer’s instructions. Co-transfection of a
b-gal-expressing plasmid, with subsequent measurement
of b-gal activity, was used to normalize luciferase data.
RT-quantitative polymerase chain reactions analysis
LNCaP cells were grown in the absence of hormone and
then treated with DHT or EtOH as described above.
Twenty-four hours following treatment, RNA was har-
vested in TRIzol reagent (Invitrogen) according to manu-
facturer’s instructions. RNA was re-suspended in
molecular biology grade ddH2O and 500ng was used in a
reverse transcription reaction to synthesize cDNA using
Oligo (dT)12–18 and SuperScript II (Invitrogen).
Quantitative polymerase chain reactions (qPCR) were
assembled in triplicate using PerfeCta SYBR Green
SuperMix (Quanta Biosciences) and transcript-speciﬁc
primers. Reactions were run on an Applied Biosystems
SDS7900HT thermal cycler in a 384-well format. Gene ex-
pression was normalized to expression of the housekeeping
gene RPL27 as described (25). Data are presented as
means±SDs and are representative of at least three inde-
pendent experiments using independently generated
batches of stable cells. Primers for the PSA gene were
described earlier (22). KLK2 primers were as follows:
forward 50 gctgggagtgtgagaagattc 30, reverse 50 gtttcaggct-
caaacaggttgtg30.Primers forRPL27weredescribed in(25).
ChIP and sequential ChIP assays
LNCaP cells were grown in 15cm plates, in the absence of
hormone, and then treated with DHT or EtOH as
described above. Cells were ﬁxed by adding formaldehyde
directly to the culture medium to a ﬁnal concentration of
1% and incubated at room temperature for 10min.
Formaldehyde was quenched by adding glycine to a ﬁnal
concentration of 125mM with incubation at room tem-
perature for an additional 5min. Cells were washed three
times in cold 1 PBS plus protease inhibitors. Cells were
then re-suspended in a nuclei isolation buffer comprising
50mM HEPES (pH 8.0), 1mM EDTA, 0.5mM EGTA,
140mM NaCl, 10% glycerol, 0.5% Igepal CA-630,
0.25% Triton X-100, plus protease inhibitors. Following
a 10min incubation on ice, nuclei were pelleted via
centrifugation and re-suspended in a buffer composed of
10mM HEPES (pH 8.0), 1mM EDTA, 0.5mM EGTA,
200mM NaCl and incubated on ice for 10min. Nuclei
were pelleted via centrifugation and re-suspended in
sonication buffer containing 50mM HEPES (pH 8.0),
140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1%
SDS, 0.5% sodium deoxycholic acid. Chromatin was
sonicated using a Branson Soniﬁer 450 to produce chro-
matin fragments with an average size of 600bp. Samples
were then centrifuged at maximum speed for 10min, 4 C.
Supernatant was used for IPs after pre-clearing with
Protein G Dynabeads (Invitrogen). 2 10
6 cells were
used per IP in a total volume of 200ml of sonication
buffer at 4 C overnight, with rotation. The following
amounts of antibodies were used per IP: AR (PG-21),
1.2mg; H3 1.5mg; H2A.Z L1 loop, 2ml serum.
Chromatin–antibody complexes were captured using
Protein G Dynabeads for 1h at 4 C with rotation.
Captured chromatin was washed sequentially, for 10min
each, in the following buffers containing fresh protease
inhibitors: Radioimmunoprecipitation assay buffer
(‘RIPA’) [150 mM NaCl, 50mM Tris–HCl (pH 8.0),
0.1% SDS, 0.5% Na–deoxycholic acid, 1% Igepal
CA-630], ‘High Salt’ [500 mM NaCl, 50mM Tris–HCl
(pH 8.0), 0.1% SDS, 1% Igepal CA-630], ‘LiCl buffer’
[250 mM LiCl, Tris–HCl (pH 8.0), 0.5% Na–deoxycholic
acid, 1% Igepal CA-630], followed by two washes in ‘TE
buffer’ [10 mM Tris–HCl (pH 8.0), 1mM EDTA]. For se-
quential ChIP assays, following the ﬁnal TE wash, chro-
matin complexes were eluted in 1% SDS, 50mM Tris–HCl
pH 7.5, 10mM EDTA for 30min at room temperature,
then diluted 10-fold in sonication buffer (minus SDS),
and subjected to a second round of ChIP using anti-HA
afﬁnity matrix. Following overnight incubation, chroma-
tin complexes were subjected to four 10-min washes in
sonication buffer, followed by two washes in TE buffer.
For both ChIP and re-ChIP, chromatin was eluted in
2 200ml of ‘elution buffer’ (2% SDS, 10mM DTT, 0.1M
sodium bicarbonate). Sixteen microliters of 5M NaCl were
added to each sample followed by reverse cross-linking at
65 C for 4–6 h. One milliliter of 95% EtOH was added to
each sample and placed at  20 C overnight. Chromatin
was pelleted via centrifugation, washed once in 70%
EtOH and re-suspended in TE buffer. Following treat-
ment of samples with RNase A and Proteinase K, DNA
was extracted using standard phenol–chloroform proced-
ures and re-dissolved in 100ml of molecular biology-grade
water. Five microliters of each sample were used for qPCR
analysis, in triplicate, as described above. The following
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forward 50 agatccaggcttgcttactgtcct 30, reverse 50
acctgctcagcctttgtctctgat 30; PSA (–)2kb forward 50
caaccaaaacctgacccaac 30, reverse 50 tttgcctggcccgtagt 30;
PSA Promoter, forward 50 tgggtcttggagtgcaaaggatct 30,
reverse 50 agacacgcccaggatgaaacagaa 30; KLK2 Enhancer
forward 50 gttgaaagcagacctactctgga 30, reverse 50 ctggacca
tcttttcaagcat 30; KLK2 Promoter, forward 50 gggaatgcctc-
cagactgat 30, reverse 50 cttgccctgttggcacct 30. Data are pre-
sented as means±SDs and are representative of at least
three independent experiments. H2A.Z ChIP data are pre-
sented as ‘H2A.Z enrichment’, to account for nucleosome
density, which was calculated by dividing the % INPUT
of the H2A.Z IPs by the % INPUT of the total H3 IPs.
RESULTS
USP10 speciﬁcally deubiquitylates H2A.Z and H2A
To test whether USP10 targets histones as substrates, we
co-expressed Flag-tagged USP10 (Flag-USP10) with
tagged H2A.Z or H2A in 293T cells and measured the
levels of ubiquitylated histones by Western blot. We have
previously determined that the mono-ubiquitylated form
of H2A.Z can be detected as a slower migrating band using
our H2A.Z-L1 antibody in Western blots (12). We have
also observed the slower migrating form of H2A using
antibodies against both the endogenous and tagged
versions of H2A. For both H2A.Z and H2A Western
blots, we further conﬁrmed that the slower migrating
species are the mono-ubiquitylated forms of the respective
histones by conducting HA-tagged ubiquitin immunopre-
cipitations (Supplementary Figure S1). Increasing expres-
sion of Flag-USP10 resulted in a corresponding reduction
of the ubiquitylated histone levels in a dose-dependent
manner (Figure 1A). Moreover, expression of USP10
alone effectively reduced the endogenous H2A.Zub1 and
H2Aub1 levels (Figure 1B). Importantly, increased USP10
expression did not affect the levels of endogenous H2Bub1
(Figure 1B), indicating that USP10 speciﬁcally targets the
H2A family of histones. Finally, this effect was dependent
on the enzymatic activity of USP10 since expression of the
catalytically inactive mutant containing the cysteine
424-to-alanine substitution (C434A) mutation (26) did
not alter the levels of ubiquitylated histones (Figure 1C).
Together, these ﬁndings show that expression of USP10
leads to a speciﬁc reduction of H2A.Zub1 and H2Aub1
levels in vivo.
We next tested whether USP10 directly targets
H2A.Zub1 and H2Aub1 by using an in vitro
deubiquitylation assay. To do so, we incubated
acid-extracted histones from 293T cells expressing either
H2A-Flag or H2A.Z-Flag with a panel of recombinant
deubiquitylases generated using the baculovirus expres-
sion system. Using an anti-Flag antibody in Western
blots, we then measured the changes in H2A.Zub1 and
H2Aub1 levels (upper band detected by the Flag
antibody, Figure 2) brought about by the activities of
the recombinant enzymes. As shown, His-tagged USP10
directly deubiquitylated H2A.Z in this assay (Figure 2, left
panel). Consistent with the in vivo results (Figure 1C), the
enzymatically inactive C424A mutant was impaired in its
ability to deubiquitylate the incubated histones. In
addition to USP10, we also tested the in vitro activities
of two other DUBs, USP16 and 2A-DUB, previously
identiﬁed to target H2Aub1 (20,22). Of all the enzymes
tested, USP16 consistently displayed the highest efﬁciency
in deubiquitylating both H2Aub1 and H2A.Zub1. USP10
and 2A-DUB have similar activities towards H2A.Zub1,
but both are less efﬁcient than USP16. Interestingly, while
USP16 has similar activity towards both H2A.Zub1 and
H2Aub1, neither USP10, nor 2A-DUB, showed signiﬁ-
cant activities towards H2Aub1 in this assay. The
previous report on 2A-DUB suggested that, in vitro,
H2A deubiquitylation was enhanced by hyper-acetylation
of the histone substrates via trichostatin A (TSA) treat-
ment (22). We therefore examined the deubiquitylation
activities of the DUBs on histone substrates harvested
from TSA-treated cells. Interestingly, we found that
TSA treatment not only increased acetylation levels of
H4, but it also led to a small but consistent increase in
the overall H2A.Zub1 and H2Aub1 levels (Figure 2).
However, in contrast to the previous report, hyper-
acetylation of H2A or H2A.Z did not enhance the
deubiquitylation of these substrates in our assay
conditions.
In summary, our in vitro assay showed that H2A.Zub1
is a direct substrate for three histone deubiquitylases:
USP16, USP10 and 2A-DUB. While USP16
deubiquitylates both H2A.Zub1 and H2Aub1, both
USP10 and 2A-DUB prefer H2A.Zub1 in vitro.I ti s
possible that additional co-factors not present in our
assay system are needed for these enzymes to target
H2A. Moreover, given that both USP10 and 2A-DUB
were reported to function in activating AR-regulated
genes, whereas USP16 was found to be important for
deubiquitylating H2Aub1 during mitosis, their differences
in activities and substrate preferences may reﬂect their dif-
ferent functions in vivo.
USP10 is localized to both the cytoplasm and nucleus
Insofar as USP10 was previously identiﬁed as a transcrip-
tional co-activator for AR-regulated genes, we wanted to
examine the subcellular distribution of this enzyme, par-
ticularly in the androgen-responsive LNCaP cell line. By
IF, we found that USP10 is present in both the cytoplasm
and the nuclei of LNCaP cells. USP10 was also previously
suggested to physically interact with AR and, therefore,
we examined the localization of this hormone receptor in
our IF studies as well. While the majority of AR is in the
cytoplasm of the hormone-deprived cells, treatment with
10nM DHT dramatically re-localized the majority of AR
to the nucleus. In contrast, DHT did not signiﬁcantly alter
USP100s distribution in the cytoplasm and nuclei of the
hormone-treated cells. Our data suggest that if USP10 and
AR do physically interact, this interaction only occurs in a
small nuclear fraction of USP10.
To examine the sub-cellular localization of USP10 with
a more quantitative method, we used a biochemical frac-
tionation assay to separate the cytoplasmic and nuclear
protein fractions from LNCaP cells. We ﬁrst compared
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DHT-treated LNCaP cells (Figure 3C). Additionally,
total levels of H2A and H2A.Z, both substrates of
USP10, were also assessed. Hormone treatment induced
a slight but consistent increase in the total levels of AR,
whereas it did not have any effect on the levels of USP10,
H2A or H2A.Z in these cells. Consistent with the IF
results, USP10 remained mostly cytoplasmic under both
conditions, whereas AR was re-localized to the nucleus
upon DHT treatment. However, a small but distinct
fraction of USP10 does reside in the nucleus and its abun-
dance is not affected by hormone treatment (Figure 3D).
Insofar as signiﬁcant amounts of USP10 are in the cyto-
plasm, it likely has cytoplasmic substrates and functions.
Indeed, USP10 regulates the stability of transmembrane
ion channels in epithelial cells (27,28), and it has recently
been reported to target cytoplasmic p53 and regulate its
protein stability (29). In contrast, the nuclear fraction of
USP10 likely has a different function, such as
transcription regulation, and since very little USP10 frac-
tionates with chromatin, it suggests that the interaction
between USP10 and chromatin is highly dynamic and
transient.
USP10 and H2A.Z regulate AR-mediated transcription
Since we did not observe a change in the distribution of
USP10 following stimulation with DHT, we wanted to
conﬁrm that it does affect AR-regulated gene expression
as reported. We ﬁrst used a luciferase-based reporter assay
in which the reporter gene is under the control of three
AREs. This is a conserved DNA sequence to which AR
binds, and is found in the regulatory regions of
androgen-responsive genes (30). In prostate cancer, PC3
cells that stably express the AR [PC-3(AR)], expression
of the AR-dependent luciferase reporter gene was indeed
induced following treatment with DHT (Figure 4A).
Co-transfection of USP10 along with the reporter con-
struct showed that USP10 enhances the DHT-induced
Figure 1. Expression of USP10 causes a reduction in H2A.Zub1 and H2Aub1 levels. (A) A Flag-tagged version of USP10, or empty vector, was
transiently co-transfected with either Flag-H2A.Z or Flag-H2A, in 293T cells. Total protein lysate was harvested and used for western blotting using
the Flag M2 antibody. (B) Flag-USP10, or empty vector, was transiently transfected into 293T cells and levels of endogenous mono-ubiquitylated
H2A.Z and H2A were assessed using antibodies that recognize both the unmodiﬁed forms (lower band) as well as the mono-ubiquitylated forms
(upper band) of the endogenous histones (see Supplementary Figure S1). As in (A), increasing expression of Flag-USP10 causes a reduction in the
levels of the mono-ubiquitylated forms of endogenous H2A.Z and H2A. However, Flag-USP10 does not affect the levels of mono-ubiquitylated
H2B, as assessed using an antibody speciﬁcally recognizing the mono-ubiquitylated form of H2B (after probing the membrane with anti-H2A.Z
antibody, the membrane was stripped and re-probed with anti-H2Bub1 antibody). (C) In contrast to wild-type Flag-USP10, co-transfection of the
catalytically inactive C424A mutant of USP10 with either Flag-H2A.Z or Flag-H2A does not affect levels of the mono-ubiquitylated forms of the
tagged histones.
Nucleic Acids Research,2011, Vol.39, No. 9 3533luciferase expression in a dose-dependent manner and its
effect is comparable to that of another AR co-activator,
the histone acetyltransferase P/CAF. More importantly,
when the PC-3(AR) cells were pre-treated with USP10
shRNA to knockdown expression of endogenous USP10,
a clear reduction in the DHT-induced luciferase level was
observed (Figure 4B). These results replicate the previous
ﬁndings by Faus et al. (24), conﬁrming that USP10 is a
bonaﬁde co-activator of AR-regulated transcription.
To further test the dependency of endogenous
AR-regulated gene expression on USP10 we examined
the expression of the well-characterized AR-activated
PSA (KLK3) gene, as well as the KLK2 gene, in
LNCaP cells. Additionally, since USP10 targets H2A.Z
for deubiquitylation, we asked if H2A.Z is involved in
regulating hormone-induced gene expression mediated
through AR. We ﬁrst generated stable LNCaP cell lines
expressing shRNAs that target USP10 or H2A.Z, and
conﬁrmed that USP10 and H2A.Z expression were
knocked down in these cells by Western blot (Figure
4C). Endogenous USP10 expression levels in the USP10
knockdown cells were <20% of the wild-type control cells,
whereas the H2A.Z expression was  50% in the H2A.Z
knockdown cells (quantiﬁcation shown in Supplementary
Figure S2). Our H2A.Z shRNA is designed to target the
30-UTR of the H2A.Z-1 transcript. Consequently, the
residual amount remaining could be contributed by the
recently discovered additional isoform of H2A.Z,
H2A.Z-2 (31,32), which may not be targeted by our
shRNA construct. Supporting our ﬁnding that USP10
targets histones, cells with stable knockdown of USP10
consistently have higher levels of H2A.Zub1 and
H2Aub1, whereas the levels of H2Bub1 remain unchanged
(Figure 4D). As measured by reverse transcription–quan-
titative PCR (RT–qPCR, Figures 4E and F), knockdown
of either H2A.Z or USP10 each resulted in reduction of
the induced levels of PSA and KLK2 mRNA relative to
the scrambled control. This effect was not due to a reduc-
tion in AR expression (Figure 4C), but suggests that
H2A.Z and USP10 are each required in the transcriptional
activation of these genes.
To test whether H2A.Z and USP10 directly regulate
expression of the AR-responsive genes, we used ChIP
assays to examine the localization of these proteins at
the PSA and KLK2 genes. Consistent with current litera-
ture, we found that, upon DHT treatment, AR is recruited
to the AREs present at the enhancers and promoters of
the PSA and KLK2 genes (Figure 5B). Also, AR enrich-
ment is much higher at the upstream enhancer than at the
promoter of the PSA gene (note that the scale of the per-
centage input for the enhancer is much higher than that
for the promoter), whereas AR levels are low and not
Figure 2. USP10 deubiquitylates H2A.Zub1 and H2Aub1 in vitro. In vitro deubiquitylation assays were assembled using a panel of His-tagged
deubiquitylases that were generated using the baculovirus protein expression system. Puriﬁed deubiquitylases were incubated with acid-soluble
protein extracts from nuclei of 293T cells expressing either Flag-tagged H2A.Z or H2A. Levels of the various deubiquitylases were compared by
Western blotting using an anti-His antibody (top panel) and levels of the mono-ubiquitylated tagged histones were assessed using the Flag M2
antibody—short exposures of the Flag blots show the unmodiﬁed band of the tagged histones for loading purposes. In order to determine if
hyper-acetylated histones are better substrates for in vitro deubiquitylation, acid-soluble protein was harvested from cells treated with TSA and
hyper-acetylation of histones was conﬁrmed using an anti-acetyl H4 antibody (bottom panel). See text for discussion.
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between these AREs. H2A.Z has been implicated in the
regulation of other hormone-induced genes, such as gluco-
corticoid receptor (GR), and the estrogen receptor (ER),
and is thought to localize at hormone receptor binding
sites (33,34). We therefore examined the enrichment of
H2A.Z, relative to total nucleosome density by also
measuring the H3 signal, at the AREs before and after
DHT treatment. We found that a signiﬁcant amount of
H2A.Z is present at the regulatory elements compared
with the control region (Figure 5C). Interestingly, there
is a consistent net loss of H2A.Z at the PSA and KLK2
enhancer and promoter regions upon DHT treatment.
This transcription activation-induced loss of H2A.Z was
conﬁrmed using two additional commercially available
antibodies against H2A.Z (data not shown), and is not
due to a change in the total protein level in response to
hormone (see Figure 3C). Such transcription-induced loss
of H2A.Z was reported earlier for a number of other genes
in mammalian cells (33,35), as well as in yeast cells (36–
39), suggesting that this is a common feature of H2A.Z
following gene activation. However, this observation is in
contrast to the recent study by Ge ´ vry et al. (34) where
hormone activation induced deposition of H2A.Z at the
ER binding sites. At present, the exact role of H2A.Z in
regulation of AR-regulated genes is not clear; however,
Figure 3. USP10 localizes to the cytoplasm and nucleus. LNCaP cells were grown on glass coverslips in charcoal-stripped, phenol red-free RPMI
1640 media for 72 h. Cells were then treated for 2 h with either DHT at a ﬁnal concentration of 10nM, or an equivalent volume of absolute EtOH.
Cells were ﬁxed and co-stained with DAPI (40,6-diamidino-2-phenylindole) and antibodies recognizing either AR (A) or USP10 (B). (C) Total protein
levels of AR and USP10 were compared, via Western blot, between LNCaP cells treated with DHT or EtOH for 2 h (H3 used as a loading control).
(D) Sub-cellular localization of USP10 and AR was determined by Western blot using cytoplasmic and nuclear fractions (S1––membrane-associated
fraction; S2––soluble cytoplasmic fraction; S3––soluble nuclear fraction; S4––chromatin-associated fraction) of LNCaP cells treated with EtOH or
DHT for 2 h. Tubulin, PARP (poly ADP-ribose polymerase) and H3 were used as loading controls for the cytoplasmic, soluble nuclear and
chromatin fractions, respectively. Sub-cellular fractions were harvested as described in ‘Materials and Methods’ section. Although AR shows a
signiﬁcant redistribution to the nuclear fraction upon treatment with hormone, USP10 does not redistribute in a similar manner. However, a distinct
fraction of USP10 does reside in the nucleus. The asterisk marks a band in the ladder that cross-reacted with the AR antibody.
Nucleic Acids Research,2011, Vol.39, No. 9 3535our expression studies showed that H2A.Z is required for
maximal induction of PSA and KLK2 expression upon
DHT treatment.
In addition to AR and H2A.Z, we have made multiple
attempts to ChIP USP10 to the PSA or KLK2 genes using
two different commercially available antibodies. However,
to date, we have not been able to consistently ChIP USP10
at the AREs of PSA and KLK2. One possibility is that
the antibodies are not suitable for ChIP. On the other
hand, given that our biochemical fractionation assay
(Figure 3D) showed that only a small amount of USP10
resides in the nucleus, it is likely that the limited amount,
Figure 4. USP10 and H2A.Z are required for full expression of AR-regulated genes. (A) PC-3 cells, stably expressing AR, were grown in the absence
of hormone, then transiently transfected with a ﬁreﬂy luciferase-expressing plasmid containing 3X AREs in the promoter, along with a plasmid
expressing either USP10, the histone acetyltransferase P/CAF, or empty vector. In all cases, an additional plasmid expressing b-galactosidase (b-gal)
was co-transfected for normalization. Cells were then stimulated with DHT (10nM) or EtOH for 24 h, after which lysates were collected for
measuring luciferase activity. Both USP10 and P/CAF stimulate the transcriptional activity of AR in a dose-dependent manner. Since USP10 and
P/CAF are in different vector backbones, their respective empty vectors were used as negative controls. (B) Cells were grown as in (A) then
co-transfected with the luciferase reporter plasmid, b-gal-expressing plasmid, and either a plasmid expressing an shRNA targeting USP10
mRNA, or a scrambled shRNA sequence control, followed by treatment with hormone or EtOH. Luciferase activity was measured 24 h after
treatment. Knockdown of USP10 reduces the transcriptional activity of AR compared with the scramble control. For (C–F), LNCaP cells were
transduced with retrovirus expressing shRNAs targeting USP10 or H2A.Z mRNA, or a non-targeting scrambled control sequence. (C) Whole-cell
lysates were used to assess USP10 and H2A.Z knockdown efﬁciencies by Western blot. Additionally, AR and H2A protein levels were examined in
the knockdown cells. Tubulin and H3 were used as loading controls. (D) Total protein lysates from LNCaP cells with stable knockdown of USP10
were used to examine the levels of H2A.Zub1, H2Aub1 and H2Bub1 by Western blot. Stable knockdown of USP10 increases the amount of both
H2A.Zub1 and H2Aub1 but not H2Bub1. Shorter exposures of the H2A.Z and H2A blots, showing the unmodiﬁed band only, as well as H3, are
used to demonstrate equal loading. (E) and (F) Transduced cells were grown in the absence of hormone for 72 h then treated with 10nM DHT or an
equivalent volume of EtOH for 24 h. RNA was harvested using TRIzol, and cDNA was synthesized and used as template for quantitative PCR
(qPCR) using primers speciﬁc for PSA (E) or KLK2 (F) mRNA. Knockdown of either USP10 or H2A.Z results in decreased expression of both PSA
and KLK2. Each PCR reaction was performed in triplicate with each experiment repeated at least three times independently, using different batches
of stable cells, also generated independently. Values are presented as means±SDs.
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matin preclude robust immunoprecipitation of this
enzyme at the AR-regulated genes. Indeed a study of
USP3, characterizing the enzyme as an H2Aub1 and
H2Bub1 DUB, reached similar conclusions (40). Despite
its prominent nuclear localization, wild-type USP3 could
not immunoprecipitate its histone substrates, and by ﬂuor-
escence recovery after photobleaching (FRAP) USP3 was
shown to have a very transient and dynamic interaction
with chromatin.
Since we do not have an antibody that speciﬁcally
detects H2A.Zub1, we generated LNCaP cells stably ex-
pressing HA-tagged ubiquitin to assess changes in the
levels of ubiquitylated proteins, including H2A.Zub1, at
the PSA and KLK2 genes before and after hormone in-
duction. ChIP analyses using anti-HA antibody showed
that ubiquitylated proteins are present at all of the
upstream regions of both PSA and KLK2 (Figure 6A).
Interestingly, total levels of ubiquitylated proteins
decreased at the PSA enhancer and both the promoter
and enhancer regions of KLK2 following stimulation
with hormone treatment. This suggests that hormone in-
duction resulted in deubiquitylation of chromatin
proteins, such as H2A and H2A.Z, and that this process
is linked to transcriptional activation. Since we were able
to readily immunoprecipitate H2A.Zub1 using HA-tagged
ubiquitin (Supplementary Figure S1), we took advantage
of this strategy to test whether H2A.Zub1 is present at the
PSA and KLK2 genes using a sequential ChIP assay by
ﬁrst immunoprecipitating chromatin using an H2A.Z
antibody, followed by a second ChIP using the HA
antibody to immunoprecipitate ubiquitin-conjugated
H2A.Z. Relative to the negative control region (between
the enhancer and promoter of the PSA gene), we observed
an enrichment of the HA–ubiquitin signal from
H2A.Z-containing chromatin at the regulatory regions
Figure 5. H2A.Z localizes to AREs at AR-regulated genes. LNCaP cells were grown in the absence of hormone for 72 h then treated with DHT
(10nM ﬁnal concentration) or an equivalent volume of EtOH for 2 h. Cells were then ﬁxed in 1% formaldehyde and chromatin was harvested for
ChIP analysis. (A) Schematic of the PSA gene. Arrows represent approximate locations of primers used in qPCR. (B) ChIP analysis of AR
recruitment to the PSA enhancer and promoter following stimulation of cells with DHT. The ‘(–) 2 kb’ label on the graphs represent the region
in between the promoter and enhancer of the PSA gene and is  2kb from the transcriptional start site. AR recruitment is speciﬁc to the AREs in the
enhancer and promoter, the majority of which is recruited to the enhancer (compare scales of Y-axes). (C) and (D) H2A.Z is localized to the
promoter and enhancer AREs in untreated cells. Following stimulation with DHT, a net loss of H2A.Z is observed at both regions. H2A.Z ChIP
data are presented as ‘H2A.Z enrichment’, to account for nucleosome density, which was calculated by dividing the % INPUT of the H2A.Z IPs by
the % INPUT of the total H3 IPs (data not shown). Each PCR reaction was performed in triplicate with each experiment repeated at least three
times independently. Values are presented as means±SDs.
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present at these regions in the absence of hormone (Figure
6B). More importantly, the H2A.Zub1 levels are reduced
following hormone induction, suggesting that
deubiquitylation of H2A.Z is part of the transcriptional
activation process.
In order to test whether USP10 affects the levels of
ubiquitylated proteins at the PSA and KLK2 genes, we
generated LNCaP cells stably expressing both HA-tagged
ubiquitin and USP10 shRNA for use in ChIP assays
(Figure 6C). In the absence of hormone (white bars) the
relative enrichment of HA–ubiquitin at the various
regions was comparable to the trend observed in cells ex-
pressing HA–ubiquitin alone (Figure 6A). In contrast,
knockdown of USP10 expression increased the retention
of ubiquitylated proteins at both the PSA and KLK2
genes following stimulation with hormone, suggesting
that USP10 directly affects the levels of ubiquitylated
proteins at these genes in response to hormone stimula-
tion. Finally, compared to cells expressing a scrambled
control shRNA, we found a consistent defect in the
eviction of H2A.Z (normally seen following hormone
stimulation) from both the PSA and KLK2 regulatory
regions in the USP10 knockdown cells (Figure 6D).
Since expression of H2A.Z is unaffected by knockdown
of USP10 (see Figure 4C) this ﬁnding strongly suggests
that USP10 is required for the transcription-induced loss
of H2A.Z at AR-regulated genes. Collectively, these data
suggest that USP10 regulates the levels of ubiquitylated
proteins at AR-regulated genes, such as H2A.Zub1 and
H2Aub1, and that eviction of H2A.Z upon transcriptional
activation is dependent on this deubiquitylase.
Figure 6. USP10 regulates levels of ubiquitylated proteins, including ubiquitylated H2A.Z, at AR-regulated genes. (A) LNCaP cells stably expressing
HA-tagged ubiquitin were used for ChIP analysis following treatment of cells with EtOH or 10nM DHT for 2 h, as described in ‘Materials and
Methods’ section. Ubiquitylated proteins were detected at both regulatory regions of the PSA and KLK2 genes, as well as the control region, which
lies between the PSA enhancer and promoter [‘(–)2 kb’]. Following treatment of cells with hormone, total levels of ubiquitylated proteins decrease at
the PSA enhancer, and KLK2 enhancer and promoter. (B) Sequential ChIP was performed as described in ‘Materials and Methods’ section using
LNCaP cells stably expressing HA-tagged ubiquitin with an anti-H2A.Z antibody followed by anti-HA antibody. The HA–ubiquitin signal
co-localizes with regions of H2A.Z enrichment at the PSA and KLK2 genes and decreases following stimulation with hormone. Fold enrichment
represents the % INPUT expressed relative to the control region, (–)2kb. (C) ChIP was performed as in (A) using cells stably expressing both USP10
shRNA and HA–ubiquitin. Although a similar trend is observed in the levels of ubiquitylated proteins at the various regions of PSA and KLK2
under vehicle-treated conditions (EtOH), a similar drop in the HA–ubiquitin signal is not observed following stimulation with hormone. (D) H2A.Z
ChIP was performed using Scramble- or USP10 shRNA-expressing cells as described. Compared with the control cells, knockdown of USP10 leads
to an increase in the retention of H2A.Z at the PSA and KLK2 genes following stimulation of cells with hormone. Data were ﬁrst calculated as %
INPUT then expressed as a percentage relative to the EtOH-treated samples. ‘(–)’ represents the no antibody, negative control samples.
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In this study, we have identiﬁed USP10 as a DUB that
targets both H2A.Zub1 and H2Aub1. Co-transfection
studies showed that USP10 speciﬁcally deubiquitylates
H2A.Zub1 and H2Aub1, but not H2Bub1, in a dose de-
pendent manner. More signiﬁcantly, stable knockdown of
USP10 expression in LNCaP cells led to a global increase
in the total H2A.Zub1 and H2Aub1 levels in these cells, as
well as an increase in the levels of ubiquitylated proteins at
AR-regulated genes. In addition, knockdown of USP10
prevented full eviction of H2A.Z at the regulatory
elements of AR-regulated genes during their transcription-
al activation. Finally, in vitro assays conﬁrmed that
H2A.Z is a direct target of USP10, as well as other
DUBs such as USP16 and 2A-DUB. Interestingly, while
USP16 has robust activity towards both H2A.Zub1 and
H2Aub1 in this assay, neither USP10, nor 2A-DUB
deubiquitylated H2Aub1 in vitro. USP16, also known as
Ubp-M, was ﬁrst described as the enzyme responsible for
deubiquitylating H2A during mitosis (19). Early studies
showed that the bulk of H2A is deubiquitylated during
mitosis and it was hypothesized that removal of the ubi-
quitin group is required to allow maximal condensation of
chromatin into chromosomes during this stage of the cell
cycle. In contrast, USP10 and 2A-DUB have been func-
tionally linked to transcriptional regulation, a process that
requires a large number of activators and co-activators.
Since USP10 and 2A-DUB affect H2A ubiquitylation
levels in vivo, but not signiﬁcantly in our in vitro assay,
it is likely that additional cofactors are required to in-
crease the efﬁciencies or expand the substrate speciﬁcities
of these enzymes in the cellular context.
H2A.Z is a highly conserved variant of H2A speciﬁcally
deposited at the promoters of a large proportion of genes
in the human and yeast genomes. This variant has been
directly linked to both transcriptional activation and re-
pression; however, its exact functions in these processes
have not yet been clearly elucidated. We have previously
found that a fraction of H2A.Z in mammalian cells is
mono-ubiquitylated and such modiﬁed form of the
variant is associated with facultative heterochromatin
(12). We also found that the transcription-repressing
PRC1 component Ring1b mediates mono-ubiquitylation
of H2A.Z, and hypothesized that the enzyme that removes
this modiﬁcation likely has an opposite function, such as
that of a transcriptional co-activator (6). In this regard,
USP10 fulﬁlls this prediction since we showed that USP10
is needed for maximal induction of AR-regulated genes.
For example, knockdown of USP10 not only reduced in-
duction of the AR-dependent luciferase reporter gene, but
it also reduced expression of the endogenous
AR-regulated PSA and KLK2 genes in DHT-treated
LNCaP cells. Recently, Zhu et al. (22) showed that the
2A-DUB enzyme also functions in the activation of
AR-regulated genes by deubiquitylating H2Aub1. Our
ﬁndings support this model and further suggest that
H2A.Z deubiquitylation is also part of this process.
Moreover, three separate DUBs, USP10, USP22 and
2A-DUB are involved in this pathway. At present, we
do not know whether they have redundant or separate
functions in AR-regulated gene expression. In addition,
it is possible that their speciﬁc functions may differ tem-
porally or in the recruitment of unique biding partners or
co-activators. This concept of histone modifying enzymes
with overlapping functions mediating AR-induced tran-
scription is not without precedence. The histone
demethylases LSD1 and JHDM2A (JMJD1A) can both
catalyse the removal of mono- and di-methyl groups from
H3 lysine 9, yet both function prominently in the tran-
scriptional activation of AR-regulated genes (42,43). The
large number of co-activators identiﬁed in this pathway
attests to the fact that AR-mediated transcriptional
regulation is highly complex and that multiple
histone-modifying activities are functionally required for
this process [see (44) for review].
To further elucidate the role of USP10 in the transcrip-
tion regulation of the DHT-induced PSA and KLK2
genes, we have made multiple attempts to ChIP this
enzyme to the enhancers and promoters of these genes.
We have used two different commercially available
antibodies against USP10 for these experiments, but
neither gave consistent results. Our IF and biochemical
fractionation analyses showed that although a fraction
of USP10 is in the nucleus of LNCaP cells, very little is
stably associated with the chromatin fraction, which sug-
gested its interaction with chromatin is highly dynamic
and transient. These factors likely contributed to the
difﬁculties of ChIP’ing this enzyme to the PSA and
KLK2 genes. A large fraction of USP10 is localized to
the cytoplasm and indeed a recent publication showed
that USP10 deubiquitylates p53 and regulates its stability
(29). Interestingly, many histone-modifying enzymes, such
as the histone acetyltransferases P/CAF and p300 (45–47),
the deacetylase SirT1 (48) and the de-methylase LSD1
(49), have all been shown to target and modify p53 as
well. The utilization of the same enzyme on both
histone, and non-histone substrates, is a common theme
in biology and illustrates the multi-functionality of PTMs
in many cellular pathways.
By ChIP analysis, we found that H2A.Z is enriched at
the enhancers and promoters of the PSA and KLK2 genes
under non-inducing conditions. Our sequential ChIP
analysis of HA-tagged ubiquitin from H2A.Z-enriched
chromatin further conﬁrms that the mono-ubiquitylated
form of H2A.Z is present at these regions in the absence
of hormone, as is the case with H2Aub1. This is the ﬁrst
direct evidence showing that ubiquitylated H2A.Z is
associated with repressed genes. Moreover, induction of
these genes upon DHT treatment led to a signiﬁcant loss
of H2A.Z at these regulatory regions, a process that is at
least partially dependent on USP10. Consistent with our
conclusion that H2A.Z is directly involved in
AR-regulated gene expression, its requirement has also
been reported for other hormone-regulation pathways
such as GR- and ER-induced genes (33,34). In addition,
the chromatin remodeling complex, Snf2-Related CBP
Activator Protein (SRCAP), which catalyses incorpor-
ation of H2A.Z into chromatin (50), has also been
described as a co-activator of AR-mediated transcription
(51,52). Interestingly, while our ﬁndings are consistent
with the GR-regulated genes in that a substantial
Nucleic Acids Research,2011, Vol.39, No. 9 3539amount of H2A.Z is enriched at the regulatory regions of
these genes prior to hormone induction, they are opposite
to ﬁndings by Ge ´ vry et al. (34) that showed that H2A.Z is
deposited to the ER-binding sites only after hormone in-
duction. In that case, they found that p400, another
H2A.Z deposition complex, is required for the
hormone-induced recruitment of H2A.Z to the
ER-binding sites. This differential usage of the chromatin
remodeling complexes (SRCAP versus p400) in the AR-
versus ER-regulated gene activation may explain the dis-
parate timing of H2A.Z deposition in these hormone
receptor-signalling pathways. However, the functional
roles of H2A.Z in these two different hormone regulation
pathways are currently unclear. Furthermore, given that
there are two isoforms of H2A.Z that differ by only three
amino acids (31,32), it would be interesting to determine
the contribution of each isoform in the regulation of these
pathways.
Our observed loss of H2A.Z upon DHT treatment and
AR recruitment is consistent with multiple studies that
showed a loss of H2A.Z upon gene activation (33,
35–39). Genome-wide studies showed that, in yeast,
H2A.Z preferentially regulates inducible genes and this
variant is often deposited at regions that ﬂank
nucleosome-free regions at the promoters (15,39,53–55).
In mammalian cells, H2A.Z is also frequently found at
regulatory elements such as promoters, enhancers and in-
sulators, which often display DNase I hypersensitivity
(33,56,57). Moreover, for GR-regulated genes, enrichment
of H2A.Z at the DNase I hypersensitive sites is lost upon
GR recruitment. This frequent loss of H2A.Z upon tran-
scriptional activation may be related to biochemical
studies that showed that H2A.Z-containing nucleosomes
are less stable (58–61). Collectively, these and other studies
suggest that H2A.Z functions to maintain a chromatin
structure that is amenable to rapid remodelling and
poised for transcriptional activation (15,16). It is of
further interest to note that acetylation of H2A.Z has
been suggested to correlate with transcriptional activation
and eviction of H2A.Z from promoter elements. Thus far,
it is not known how H2A.Z ubiquitylation might affect
this process. One hypothesis is that ubiquitylation of
H2A.Z may alter nucleosome stability and impede
H2A.Z eviction and thus deubiquitylation of H2A.Zub1
is a pre-requisite step for transcription activation. Further
studies testing this hypothesis will be important for
determining how H2A.Z deubiquitylation might function
in transcriptional regulation.
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